High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
|Articles|January 16, 2018
- The Column-01-16-2018
- Volume 14
- Issue 1
Vol 14 No 1 The Column January 2018 Europe and Asia PDF
Click the title above to open The Column January 2018 Europe & Asia issue, Volume 14, Number 1, in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
New Year’s Resolution(s)almost 9 years ago
Combatting Antimicrobial Resistance Through VOC Analysis of RTIsalmost 9 years ago
Biotage Acquires Horizon Technologyalmost 9 years ago
Tackling Chagas Disease With Proteomics and LC–MS/MSalmost 9 years ago
The Benefits of AQbDalmost 9 years ago
Five Things You May Not Know About GCalmost 9 years ago
Vol 14 No 1 The Column January 2018 North American PDFAdvertisement
Related to this article
Nano-liquid chromatography-high-resolution tandem mass spectrometry (nano-LC-HRMS/MS) reveals saliva protein shifts before and after multiple sclerosis therapy.
Max Besenhard explains how hybrid mechanistic and machine learning models can make HPLC method development quicker, more robust and ready for autonomous digital twins.
Ultra-high purity BIP® cylinders aim to give analytical laboratories cleaner baselines and lower detection limits
Polymer sorbent and dual microextraction boost gas chromatography with flame ionization detection (GC-FID) pesticide analysis.
Untargeted liquid chromatography–mass spectrometry (LC–MS) ties job stress in workers to plasma lipid changes.
Ultrahigh-pressure liquid chromatography–quadrupole time-of-flight mass spectrometry (UHPLC–QTOF MS) shows diet shapes honeybee metabolic responses to heat.
Advertisement
Advertisement
Trending on LCGC International
1
Industry Roundup: Air Products Advances Gas Chromatography Performance
2
Fast Low-Pressure Chiral GC for Pesticides in Wine
3
AI/ML Now: Hybrid Machine Learning for Experiment-Efficient HPLC
4
Nano-LC-MS/MS Tracks Saliva in Multiple Sclerosis
5